U3 Pharma

What U3 Pharma does

U3 Pharma is a German pharmaceutical company founded in 2001 and headquartered in Planegg, Germany, focused on the development of targeted therapeutics for cancer. The company operated in the oncology drug-discovery space with a headcount in the 11-50 range, characteristic of a venture-backed, pre-clinical or early-clinical-stage biotech. According to the available data, U3 Pharma raised approximately $50.77 million across two venture financing rounds, the first in October 2003 (~€16.8M led by Atlas Venture and LCF Rothschild with BioM Venture Capital) and the second in May 2006 ($34M led by LSP BioVentures with Alta Partners, Atlas Venture, Bio*One Capital, and Edmond de Rothschild Private Equity), reflecting steady capital scaling consistent with pipeline progression.

U3 Pharma's underlying technology and product platform are not detailed in the available data, but as a targeted cancer drug development firm, its value is presumed to reside in proprietary biological targets, small-molecule or biologic drug candidates, and associated intellectual property developed by a concentrated team of oncology researchers. The company's customers, in a commercial sense, are not end-users or patients; rather, its stakeholders are R&D collaborators, licensing partners, and ultimately large pharmaceutical acquirers or co-development counterparties typical of European oncology biotechs at this stage.

Data-quality caveat: a substantial portion of the input describes a Vietnamese-language health-information website (u3pharma.com) built on WordPress, publishing medication and disease articles in Vietnamese and generating advertising revenue. This website appears to be a separate, unrelated entity that has been conflated with the German pharmaceutical company record. The German biotech profile is treated as primary because it is consistent with the firmographic data (location, sector, founding year) and with the investor syndicate disclosed in the funding rounds.

Name

U3 Pharma

Legal name

U3 Pharma

Website

https://u3pharma.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

U3 Pharma is a German pharmaceutical company founded in 2001 and based in Planegg, Germany, focused on targeted cancer drug development. The venture-backed biotech raised approximately $50.8 million across two funding rounds from specialist life-sciences investors between 2003 and 2006.

Ownership category

akta.pro rank

Headquarters

HQ city

Planegg

HQ country

Germany

HQ region

Europe

Markets served

GTM type

B2C

Offering type

Digital Commerce or Content

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Digital advertising: The website generates revenue through advertising placements, likely display ads and sponsored content. The site contains promotional content for educational institutions and pharmaceutical products.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

U3 Pharma operates a Vietnamese-language health information website (u3pharma.com) that publishes articles covering medications, common diseases, medical news, blood test indicators, drug dosage guidance, and wellness tips. The portal is a free content resource aimed at Vietnamese readers seeking healthcare and medication information, organized into categories such as Thuốc (Medications), Bệnh Thường Gặp (Common Diseases), Tin Y Tế (Medical News), and Cẩm Nang Sức Khỏe (Health Handbook).

Product overview

U3 Pharma is a health information portal website, not a product company with a sellable platform or modules. It operates as a content/educational website providing Vietnamese-language healthcare news, medication guides, disease information, and health tips. The site does not offer any distinct branded products, SaaS tools, APIs, or mobile applications - it is solely a news and information aggregation website covering pharmaceutical and medical topics.

Differentiator

Problem solved

Functional benefit

Products and services

• U3 Pharma Health Information Portal A Vietnamese healthcare news and information website that provides free educational content about medications, common diseases, medical news, blood test indicators, and health tips. The portal is organized into categories including Thuốc (Medications), Bệnh Thường Gặp (Common Diseases), Tin Y Tế (Medical News), and Cẩm Nang Sức Khỏe (Health Handbook), aimed at Vietnamese readers seeking reliable health and medication information.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves3 records

Expansion highlights3 records

Direct peers

• Hello Bacsi: A leading Vietnamese-language health information and telemedicine platform offering medically reviewed articles, doctor booking, and health tools. Directly comparable as a consumer-facing Vietnamese health-content destination with overlapping medication and disease-information coverage.
• BookingCare: Vietnamese healthcare booking and information platform serving consumers with hospital/clinic listings and health articles. Comparable as a Vietnamese-language consumer health-information site monetized through healthcare-provider partnerships.
• YouMed: Vietnamese health-tech platform combining doctor booking with a health articles/knowledge base in Vietnamese. Comparable as a consumer-facing Vietnamese health-information site with adjacent transactional features.

Broad incumbents

• Vinmec: Vietnam's largest private hospital network operated by Vingroup, which also publishes an extensive Vietnamese-language health-content library through vinmec.com. Comparable as a larger, institutionally backed Vietnamese health-information publisher with overlapping disease and medication coverage.
• Suckhoedoisong.vn: Official online newspaper of the Vietnamese Ministry of Health covering medical news, disease prevention, and medication guidance. Comparable as an authoritative Vietnamese-language health-content publisher competing for the same organic search queries.
• Medlatec: Major Vietnamese medical laboratory and healthcare services group that also publishes health-information content for consumers. Comparable as a Vietnamese healthcare provider that uses health content as a top-of-funnel consumer engagement tool.

Emerging players

• eDoctor: Vietnamese telehealth and health-information app providing remote consultations and health articles. Comparable as a Vietnamese-language consumer health-content platform with a mobile-first distribution model.
• Doctor24h: Vietnamese telehealth platform publishing health articles and offering online consultations. Comparable as a Vietnamese-language consumer health-information site competing for the same medication and disease queries.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks6 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds2 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about U3 Pharma